Generated by GPT-5-mini| Select Agent Program | |
|---|---|
| Name | Select Agent Program |
| Formed | 1996 |
| Jurisdiction | United States |
| Parent agency | Centers for Disease Control and Prevention; Animal and Plant Health Inspection Service |
Select Agent Program
The Select Agent Program regulates possession, use, and transfer of designated biological agents and toxins to protect public health, animal health, and plant health. It intersects with Centers for Disease Control and Prevention, Department of Agriculture (United States), Department of Health and Human Services, and Department of Homeland Security authorities, influencing policy, laboratory practice, and biosafety across research, clinical, veterinary, and agricultural sectors.
The program lists specific biological agents and toxins subject to control, aligning with statutes such as the Antiterrorism and Effective Death Penalty Act of 1996 and the Bioterrorism Act of 2002, while coordinating implementation through Federal Select Agent Program components housed at Centers for Disease Control and Prevention and Animal and Plant Health Inspection Service. It delineates requirements for laboratories handling agents like Bacillus anthracis, Francisella tularensis, Yersinia pestis, and toxins such as ricin and botulinum toxin. The program engages with institutions including National Institutes of Health, Food and Drug Administration, Environmental Protection Agency, State Department (United States), and academic centers like Johns Hopkins University, Harvard University, and University of Pennsylvania for research oversight and risk mitigation.
Legal authority derives from statutes and regulations: the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 amended by regulations in the Code of Federal Regulations Title 42 and Title 9, and is enforced through rulemaking by Centers for Disease Control and Prevention and Animal and Plant Health Inspection Service. Judicial and legislative contexts include cases and hearings involving Congress of the United States committees, oversight by Government Accountability Office, and interactions with policies from Homeland Security Presidential Directive frameworks. Internationally, coordination touches on World Health Organization norms, World Organisation for Animal Health, and treaty frameworks such as the Biological Weapons Convention.
Entities seeking to possess listed agents must register with the appropriate component of the program, submit detailed inventories, and document security measures in coordination with local law enforcement and federal authorities including Federal Bureau of Investigation and Department of Homeland Security. Registrants address physical security, access control, and biosafety measures comparable to standards advanced by National Institutes of Health guidelines and Centers for Disease Control and Prevention biosafety manuals. High-consequence agents designated as Tier 1 require enhanced personnel reliability programs, performance of risk assessments, and inventories managed under federal inspection regimes similar to protocols used in collaborations with Department of Defense laboratories such as US Army Medical Research Institute of Infectious Diseases.
Laboratory compliance covers facility design, containment levels, biosafety cabinets, decontamination, and waste management consistent with Biosafety in Microbiological and Biomedical Laboratories guidance and institutional biosafety committees at academic centers like Massachusetts Institute of Technology and University of California, Berkeley. Personnel suitability includes background checks, security risk assessments, and training records coordinated with agencies like Federal Bureau of Investigation and local state health departments. Compliance programs integrate with institutional review boards, occupational health services at hospitals such as Mayo Clinic and Cleveland Clinic, and with accreditation standards from organizations such as College of American Pathologists.
Incident response involves notification procedures to Centers for Disease Control and Prevention, coordination with Federal Bureau of Investigation, state public health laboratories, and agricultural responders including Animal and Plant Health Inspection Service teams. Inspections are conducted by federal inspectors, with findings leading to corrective action plans, temporary suspensions, or revocations of registration; enforcement actions have been informed by reports from the Government Accountability Office and congressional oversight. Outbreak responses integrate with programs at Centers for Disease Control and Prevention, emergency response frameworks such as National Incident Management System, and interagency exercises involving National Institutes of Health and Department of Defense partners.
The program affects basic and translational research across institutions like Rockefeller University, Scripps Research, and Cold Spring Harbor Laboratory by imposing administrative, security, and training burdens that influence study design, specimen sharing, and international collaboration with partners in United Kingdom, Canada, and Australia. Public health laboratories, including State Public Health Laboratories Association members, balance pathogen surveillance for agents such as Ebola virus and SARS-CoV-2 with regulatory compliance. Agricultural surveillance programs for agents affecting livestock and crops coordinate with United States Department of Agriculture and regional labs to protect industries tied to states like Iowa and California.
Origins trace to congressional responses to bioterrorism concerns in the 1990s and early 2000s, following events that prompted legislation like the Antiterrorism and Effective Death Penalty Act of 1996 and the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Implementation evolved through rulemaking by Centers for Disease Control and Prevention and Animal and Plant Health Inspection Service, informed by scientific advisory groups, incident reviews involving facilities such as Centers for Disease Control and Prevention laboratories, and recommendations from bodies like the National Research Council and National Academies of Sciences, Engineering, and Medicine. The program continues to adapt through policy changes influenced by outbreaks, biosecurity audits, and federal initiatives in fields involving institutions such as NIH and FDA.
Category:United States federal health programs